Our Pricing

Wegovy Pen In Stock UK - Available All Doses

Finding a wegovy pen in stock uk pharmacy with all doses available can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain consistent stock of Wegovy semaglutide pens across all licensed doses, with transparent pricing from £79.00 and same-day prescription approval available subject to clinical assessment by our UK-registered prescribers.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural GLP-1 hormone, which regulates appetite by acting on brain centres that control hunger and satiety, whilst also slowing gastric emptying to increase feelings of fullness after meals.

In the landmark STEP 1 clinical trial involving 1,961 adults, participants using Wegovy 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Approximately 50% of trial participants lost at least 15% of their initial body weight, with some achieving reductions exceeding 20% when combined with lifestyle modifications [2].

The medication works by reducing hunger signals and increasing satiety hormones, making it easier for patients to adhere to reduced-calorie diets without the intense cravings that typically derail weight loss efforts. Clinical outcomes demonstrate sustained weight reduction when treatment continues, though weight regain may occur if the medication is discontinued without maintained lifestyle changes.

Wegovy Pen Doses: Complete UK Dosing Schedule

Wegovy follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising therapeutic efficacy. The UK-licensed dosing schedule begins at 0.25mg weekly for the first month, increasing gradually every four weeks: 0.5mg (month 2), 1mg (month 3), 1.7mg (month 4), reaching the maintenance dose of 2.4mg from month 5 onwards [3].

Each Wegovy pen contains four pre-filled doses for one month of treatment. The gradual titration allows your digestive system to adapt to semaglutide's effects on gastric motility, significantly reducing the likelihood of nausea, vomiting, or diarrhoea that can occur with rapid dose increases. At Cured Pharmacy, we maintain stock of all five dose strengths, ensuring uninterrupted treatment progression without delays between titration stages.

Patients who experience persistent gastrointestinal symptoms during escalation may remain at their current dose for an additional four weeks before advancing, subject to prescriber guidance. The 2.4mg maintenance dose has demonstrated optimal efficacy in clinical trials, though some patients achieve their weight loss goals at lower maintenance doses of 1.7mg depending on individual response and tolerability.

What Happens If I Miss a Dose?

If you miss your weekly Wegovy injection and it has been less than five days since your scheduled dose, administer it as soon as you remember. If more than five days have passed, skip the missed dose entirely and resume your regular schedule with the next planned injection [3]. Never double up doses to compensate for a missed injection, as this significantly increases the risk of severe gastrointestinal side effects and does not improve therapeutic outcomes.

Wegovy Stock Availability Across UK Pharmacies

Since Wegovy's UK launch in 2023, intermittent supply constraints have affected availability across doses, particularly the starter 0.25mg pens and maintenance 2.4mg strength. Manufacturer Novo Nordisk has worked to increase production capacity, though demand continues to exceed supply in many regions. At Cured Pharmacy, we prioritise stock allocation for continuing patients to prevent treatment interruptions that can compromise weight loss progress.

Our pharmacy team monitors stock levels daily and maintains relationships with multiple licensed wholesalers to secure consistent supply across all five dose strengths. When you complete your online consultation with our UK prescribers, we verify current stock availability before confirming your prescription, ensuring your treatment begins without delay. Patients already established on Wegovy receive priority allocation to maintain therapeutic continuity.

If a specific dose is temporarily unavailable industry-wide, our clinical team will contact you to discuss appropriate alternatives, which may include remaining at your current dose for an extended period or, in some cases, considering equivalent GLP-1 treatments with better availability, always subject to prescriber approval and your individual clinical suitability.

Wegovy Pen In Stock UK: How to Order from Cured Pharmacy

Ordering your wegovy pen in stock uk from Cured Pharmacy takes under three minutes. Begin by completing our free online consultation questionnaire, which gathers essential medical history including current medications, previous weight loss attempts, cardiovascular health, and any contraindications to GLP-1 therapy. Our UK-registered prescribers review every consultation individually—this is not an automated approval process.

Once your consultation is approved, typically within 24 hours on weekdays, we dispense your Wegovy pen from our GPhC-registered pharmacy (registration number 9012511) and arrange discreet next-day delivery via Royal Mail or DPD. All packaging is plain and unmarked, with no external indication of contents. Your medication arrives with full patient information leaflets, injection technique guidance, and direct contact details for our pharmacy team should you have questions during treatment.

Prescription costs are transparent before you begin the consultation—from £79.00 depending on dose and quantity. There are no hidden consultation fees, and our lowest price guarantee ensures you receive competitive UK pricing without compromising on clinical safety or medication authenticity. All Wegovy pens supplied are UK-licensed products sourced through legitimate pharmaceutical supply chains, never grey imports or unlicensed preparations.

Who Can Prescribe Wegovy in the UK?

Wegovy is a prescription-only medicine in the UK and must be prescribed by a registered medical practitioner following clinical assessment. At Cured Pharmacy, consultations are reviewed by our team of UK-registered GPs and prescribing pharmacists, including our superintendent pharmacist Tarun Kumar (GPhC 2233073), who oversee all clinical decisions and ensure prescribing complies with MHRA guidance and NICE recommendations for weight management.

Wegovy Side Effects and Safety Considerations

The most common side effects of Wegovy are gastrointestinal, affecting approximately 44% of patients in clinical trials [1]. These include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases and diminishing as treatment continues. Most patients find these effects manageable with dietary adjustments—eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce symptom severity.

Serious but rare adverse effects include pancreatitis (inflammation of the pancreas), gallbladder disease including gallstones, and hypoglycaemia in patients taking concurrent diabetes medications. Wegovy carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though no causal link has been established in humans [3]. Patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Wegovy.

Before starting treatment, inform your prescriber of all current medications, particularly other diabetes treatments, as dose adjustments may be necessary to prevent low blood sugar. Wegovy may slow absorption of oral medications due to delayed gastric emptying, potentially affecting efficacy of oral contraceptives or other time-sensitive medications. Women of childbearing potential should use reliable contraception, as semaglutide should be discontinued at least two months before planned pregnancy.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that does not resolve, persistent vomiting preventing fluid intake, signs of allergic reaction (rash, difficulty breathing, facial swelling), or visual changes. Contact our pharmacy team on (+44) 116 4646009 if you have concerns about side effects or treatment response—our clinical team is available to provide guidance and arrange prescriber review when clinically indicated.

Wegovy vs Other Weight Loss Treatments Available in the UK

Several prescription weight loss treatments are licensed in the UK, each with distinct mechanisms, efficacy profiles, and suitability criteria. Wegovy's once-weekly injectable format offers convenience compared to daily alternatives, whilst its average 14.9% weight reduction in clinical trials positions it among the most effective pharmaceutical options currently available [1][2].

Saxenda contains liraglutide, an earlier-generation GLP-1 agonist requiring daily subcutaneous injection. Clinical trials demonstrated average weight loss of 8% over 56 weeks—effective, but notably less than Wegovy's outcomes [4]. The daily injection schedule can be burdensome for some patients, though others prefer the flexibility of adjusting timing around their daily routine. Saxenda may suit patients who prefer lower upfront costs with daily dosing over weekly injections.

Orlistat (also sold as Xenical) works through a completely different mechanism, blocking approximately 30% of dietary fat absorption in the intestines. It requires three-times-daily dosing with meals and can cause gastrointestinal side effects if high-fat foods are consumed. Average weight loss with orlistat is approximately 5-10% when combined with calorie restriction [4]. Unlike GLP-1 treatments, orlistat does not suppress appetite, requiring greater reliance on conscious dietary restriction.

Your suitability for Wegovy versus alternatives depends on your medical history, BMI, weight-related comorbidities, previous treatment responses, and personal preferences regarding injection frequency and side effect profiles. Our UK prescribers assess these factors during your consultation to recommend the most appropriate option for your individual circumstances, always prioritising clinical safety alongside efficacy.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. Retrieved from https://www.nice.org.uk/guidance/cg189

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.